Merck’s Millipore Bid May Leave Investors Waiting for Return

Merck’s Millipore Bid May Leave Investors Waiting for Return
March 2 (Bloomberg) — Merck KGaA’s $6 billion agreement to acquire Millipore Corp. , the U.S. supplier of equipment to biotechnology companies, may leave investors waiting longer for the “pure value creation” the German company promised three years ago when it bought Serono SA, analysts said.

Read more on Bloomberg